ALEXANDRIA, Va., Aug. 19 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'MO-REZ' in its latest official gazette. The trademark application with the serial number 50002501 was filed on Jul. 20, 2026.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for the treatment of oncological diseases and disorders.
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Glaxo Group Limited GSK Medicines Research Centre Gunnels Wood Road Stevenage GB United Kingdom SG12NY 77 PRIVATE COMPANY LIMITED BY SHARES
Disclaimer: Curated by HT Syndication....